| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 295.69B | 291.87B | 300.83B | 298.76B | 261.16B | 191.89B |
| Gross Profit | 27.06B | 27.38B | 25.33B | 22.32B | 18.74B | 15.60B |
| EBITDA | 20.65B | 21.20B | 11.90B | 20.48B | 18.17B | 12.72B |
| Net Income | -6.18B | 4.73B | -6.92B | 1.68B | 1.73B | 209.00M |
Balance Sheet | ||||||
| Total Assets | 167.71B | 182.64B | 177.56B | 191.77B | 176.14B | 160.93B |
| Cash, Cash Equivalents and Short-Term Investments | 13.87B | 18.73B | 14.36B | 12.20B | 5.49B | 1.98B |
| Total Debt | 67.91B | 68.95B | 72.59B | 76.06B | 73.92B | 64.86B |
| Total Liabilities | 106.06B | 110.94B | 113.31B | 120.03B | 111.38B | 100.35B |
| Stockholders Equity | 49.11B | 58.13B | 51.51B | 55.83B | 50.04B | 45.11B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 10.76B | 6.71B | 10.60B | 1.75B | -14.15B |
| Operating Cash Flow | 0.00 | 20.53B | 14.76B | 19.47B | 17.43B | 1.79B |
| Investing Cash Flow | 0.00 | -9.68B | -7.87B | -8.90B | -16.34B | -15.64B |
| Financing Cash Flow | 0.00 | -6.94B | -5.73B | -4.26B | 2.34B | 11.57B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | ¥236.02B | 8.29 | ― | 3.36% | 4.89% | 44.89% | |
78 Outperform | ¥72.40B | 7.48 | 11.87% | 5.00% | -5.74% | -17.86% | |
68 Neutral | ¥208.54B | 29.39 | ― | 4.77% | -3.95% | -13.75% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
61 Neutral | ¥397.21B | -20.09 | 3.70% | 3.42% | 4.24% | 39.02% | |
55 Neutral | ¥11.80B | 2.70 | ― | 2.45% | -2.98% | ― | |
52 Neutral | ¥17.73B | 9.98 | ― | 3.19% | -1.17% | ― |